Literature DB >> 17872564

alpha2delta ligand: a new, smart pill for visceral pain in patients with hypersensitive irritable bowel syndrome?

Michael Camilleri1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17872564      PMCID： PMC2000245          DOI： 10.1136/gut.2007.127514

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  21 in total

1.  Visualization of the domain structure of an L-type Ca2+ channel using electron cryo-microscopy.

Authors:  M Wolf; A Eberhart; H Glossmann; J Striessnig; N Grigorieff
Journal:  J Mol Biol       Date:  2003-09-05       Impact factor: 5.469

2.  Antinociceptive effect of pregabalin in septic shock-induced rectal hypersensitivity in rats.

Authors:  H Eutamene; A M Coelho; V Theodorou; M Toulouse; M Chovet; A Doherty; J Fioramonti; L Bueno
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

3.  Pregabalin: a new neuromodulator with broad therapeutic indications.

Authors:  Bassel F Shneker; James W McAuley
Journal:  Ann Pharmacother       Date:  2005-11-15       Impact factor: 3.154

4.  Irritable bowel syndrome patients show altered sensitivity to exogenous opioids.

Authors:  Tony Lembo; Bruce D Naliboff; Kamran Matin; Julie Munakata; Robert A Parker; Richard H Gracely; Emeran A Mayer
Journal:  Pain       Date:  2000-08       Impact factor: 6.961

5.  Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C.

Authors:  Jill C Fehrenbacher; Charles P Taylor; Michael R Vasko
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

6.  Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans.

Authors:  B E Viramontes; A Malcolm; M Camilleri; L A Szarka; S McKinzie; D D Burton; A R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-12       Impact factor: 4.052

7.  Lipid-induced colonic hypersensitivity in irritable bowel syndrome: the role of 5-HT3 receptors.

Authors:  M Simrén; L Simms; D D'Souza; H Abrahamsson; E S Björnsson
Journal:  Aliment Pharmacol Ther       Date:  2003-01       Impact factor: 8.171

8.  Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone.

Authors:  M Bradette; M Delvaux; G Staumont; J Fioramonti; L Bueno; J Frexinos
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

9.  Effects of the somatostatin analogue octreotide on rectal afferent nerves in humans.

Authors:  V Plourde; T Lembo; Z Shui; J Parker; H Mertz; Y Taché; B Sytnik; E Mayer
Journal:  Am J Physiol       Date:  1993-10

10.  Pregabalin (CI-1008) inhibits the trinitrobenzene sulfonic acid-induced chronic colonic allodynia in the rat.

Authors:  Laurent Diop; Frederic Raymond; Helene Fargeau; Francine Petoux; Maria Chovet; Annette M Doherty
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030
View more
  3 in total

Review 1.  Targeting voltage-gated sodium channels for treatment for chronic visceral pain.

Authors:  Fei-Hu Qi; You-Lang Zhou; Guang-Yin Xu
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  Effect of the α2δ ligand, pregabalin, on colonic sensory and motor functions in healthy adults.

Authors:  Johanna Iturrino; Michael Camilleri; Irene Busciglio; Duane Burton; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-05-19       Impact factor: 4.052

3.  Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome.

Authors:  Johanna Iturrino; Michael Camilleri; Irene Busciglio; Duane Burton; Alan R Zinsmeister
Journal:  Dig Liver Dis       Date:  2013-10-04       Impact factor: 4.088
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.